Omeprazole Teva

Omeprazole, the active ingredient in Omeprazole Teva, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children. GNH USA supplies Omeprazole Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on gastric acid secretion. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of esophageal irritation. - Erosive esophagitis: accelerates mucosal healing and reduces recurrence. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Abdominal pain: discomfort in the upper abdomen. - Nausea: occasional feeling of queasiness. - Diarrhea: loose stools, usually transient. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic enzyme elevation: increased ALT/AST levels. - Hypomagnesemia: low serum magnesium with possible muscle cramps or arrhythmias.

When prescribing Omeprazole, consider the following safety measures. - Assess renal and hepatic function: adjust use in severe impairment. - Monitor long‑term therapy: evaluate bone health and fracture risk. - Avoid in known hypersensitivity: discontinue if allergic reaction occurs. - Caution with concomitant warfarin: monitor INR closely. - Use during pregnancy only if clearly needed: discuss risks with the prescriber. - Store below 25°C: keep in the original pack, protect from moisture.

Omeprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, may increase cardiovascular risk. - Ketoconazole or itraconazole: decreased absorption due to higher gastric pH. - CYP2C19 inhibitors (e.g., fluconazole): increased omeprazole plasma levels.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of INR, require closer monitoring. - Digoxin: possible increase in serum concentration. - Methotrexate (high dose): reduced renal clearance, monitor toxicity. - HIV protease inhibitors (e.g., atazanavir): decreased efficacy, consider alternative therapy.